Denali Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Denali Therapeutics Inc. has filed 775 SEC EDGAR filings since 08 Sep 2017

SEC filing history

Showing 51-54 of 54 matching filings.

Per page
25
Current page
3
SC 13G File 005-90223

ARCH VIII - DENALI THERAPEUTICS INC. 13G

Filing date
02 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90223

SC 13G filing

Filing date
31 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90223

SC 13G/A filing

Filing date
22 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90223

SC 13G filing

Filing date
15 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .